Home / Filing-delay notices (10-Q) / Esperion Therapeutics, Inc.
Filed 2025-08-11 路 Form NT 10-Q 路 Accession 0001628280-25-039562 small
Price before filing: $0.0118 (2025-08-08 close, split/dividend-adjusted)
Market cap at flag: $366.6M (2025-08-11) 路 Latest: $799.3M (2026-07-14)
| Window | ESPR | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +39.0% | +2.4% | +36.7% | 2025-09-10 |
| 90 days | +54.0% | +7.2% | +46.8% | 2025-11-10 |
| 180 days | +77.5% | +9.5% | +68.0% | 2026-02-09 |
| 1 year | n/a | n/a | n/a | no price after 2026-07-14 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
The company filed Form NT 10-Q, telling the SEC it could not file its quarterly report on time, and then filed the report within the 5-day extension. The SEC treats a report filed within the extension as timely, so this is the mildest kind of flag, but the notice itself is a warning sign that investors often react to: something, often the audit or the accounting, took longer than planned.
Status: filed within extension (report filed 2025-08-13) · the SEC treats a report filed within the extension as timely
Why this score: report filed within the extension on 2025-08-13
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.